§ feed · storyline
Metis TechBio surges 185% on Hong Kong debut after $270M IPO
Metis TechBio surges 185% on its Hong Kong market debut after raising $270M in an IPO for its AI-driven drug delivery and formulation platform.
Amber Tong / Bloomberg: Metis TechBio, a biotech company using AI to deliver and formulate drugs, surged as much as 185% in its Hong Kong market debut after raising ~$270M in its IPO — Shares of Metis TechBio Co, a biotechnology company using artificial intelligence to deliver and formulate drugs …
§ sources1 publication · timeline below